Skip to main content
TipRanks
Go Ultimate75% OFF

Genor Biopharma Holdings Limited (6998) Financial Statements

3 Followers

Genor Biopharma Holdings Limited Financial Overview

Genor Biopharma Holdings Limited's market cap is currently ¥3.16B. The company's EPS TTM is ¥0.31; its P/E ratio is 4.34; Genor Biopharma Holdings Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 2.70B¥ 2.76B¥ 0.00¥ 18.53M¥ 0.00
Gross Profit¥ 1.76B¥ 1.78B¥ -84.96M¥ -45.04M¥ -73.21M
Operating Income¥ 689.46M¥ 713.61M¥ -771.77M¥ -914.26M¥ -1.11B
EBITDA¥ 933.65M¥ 907.79M¥ -694.88M¥ -860.58M¥ -1.05B
Net Income¥ 433.01M¥ 420.56M¥ -745.17M¥ -849.15M¥ -1.04B
Balance Sheet
Cash & Short-Term Investments¥ 1.06B¥ 1.06B¥ 1.17B¥ 1.59B¥ 2.20B
Total Assets¥ 6.61B¥ 1.29B¥ 1.45B¥ 2.12B¥ 2.86B
Total Debt¥ 1.49B¥ 911.00K¥ 7.16M¥ 28.59M¥ 57.41M
Net Debt¥ 431.36M¥ -1.06B¥ -1.16B¥ -1.56B¥ -2.14B
Total Liabilities¥ 2.75B¥ 138.05M¥ 256.18M¥ 309.87M¥ 369.73M
Stockholders' Equity¥ 3.86B¥ 1.15B¥ 1.19B¥ 1.80B¥ 2.49B
Cash Flow
Free Cash Flow¥ 404.05M¥ -123.55M¥ -426.15M¥ -590.56M¥ -695.13M
Operating Cash Flow¥ 451.73M¥ -121.98M¥ -425.12M¥ -577.61M¥ -623.74M
Investing Cash Flow¥ 1.24B¥ 8.01M¥ 5.99M¥ -12.94M¥ -54.26M
Financing Cash Flow¥ -744.78M¥ -1.56M¥ -6.82M¥ -57.39M¥ 17.57M

Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History

-4B04B8B-40000 %-20000 %0 %20000 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

Genor Biopharma Holdings Limited Liabilities to Assets

02.5B5B7.5B0 %25 %50 %75 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Genor Biopharma Holdings Limited Cash Flow

-2B-1B01B2B3B4B20182019202020212022202320242025OperatingInvestingFinancing

Genor Biopharma Holdings Limited Forecast EPS vs Actual EPS

-0.4-0.200.20.40.6Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss